Stay updated with breaking news from Clinical Project. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The 'Global Clinical Trials Connect 2022' conference has been added to ResearchAndMarkets.com's offering. The Global Clinical Trials Connect...
Dublin, June 23, 2022 (GLOBE NEWSWIRE) -- The "Global Clinical Trials Connect 2022" conference has been added to ResearchAndMarkets.com's offering. The...
STOCKHOLM, SE / ACCESSWIRE / April 21, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Engitix Ltd (‘Engitix’), a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours and with two significant partnerships based on its pioneering proprietary human extracellular matrix (ECM) drug discovery platform, today announced that it has appointed Dr Mike Burbridge, as Vice President, Oncology & Immuno-oncology. Dr Gino Van Heeke, Engitix’s CSO said “We are delighted to have attracted a scientist as high calibre as Mike, who has the experience and expertise to help push forward our internal therapeutic projects as well as our partnered programmes...